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ABSTRACT: Male Long–Evans rats sustained injections of 5,7-
dihydroxytryptamine (5,7-DHT) into the ﬁmbria-fornix and the
cingular bundle or/and intraseptal injections of 192 IgG-saporin
to induce serotonergic or/and cholinergic hippocampal dener-
vations; Sham-operated rats served as controls. Four to ten
weeks after lesioning, we measured (i) the electrically evoked
release of acetylcholine ([3H]ACh), noradrenaline ([3H]NA) and
serotonin ([3H]5-HT) in hippocampal slices in the presence
of drugs acting on auto- or heteroreceptors, (ii) the nicotine-
evoked release of NA and (iii) the choline acetyltransferase
(ChAT) activity and the concentration of monoamines in ho-
mogenates. Saporin lesions reduced the accumulation of
[3H]choline, the release of [3H]ACh and the ChAT activity, but
increased the concentration of NA and facilitated the release
of [3H]NA evoked by nicotine. 5,7-DHT lesions reduced the
accumulation and the release of [3H]5-HT, the concentration
of 5-HT, and also facilitated the release of [3H]NA evoked
by nicotine. Accumulation and electrically evoked release
of [3H]NA were not altered by either lesion. The combina-
tion of both toxins resulted in an addition of their particular
effects. The 5-HT1B receptor agonist, CP 93,129, and the
muscarinic agonist, oxotremorine, reduced the release of
[3H]ACh in control and 5,7-DHT-lesioned rats; in rats injected
with saporin, their effects could not be measured reliably. CP
93,129 and the α2-adrenoceptor agonist, UK 14,304, reduced
the release of [3H]5-HT in all groups by about 65%. In con-
clusion: (i) selective neurotoxins can be combined to enable
controlled and selective damage of hippocampal transmit-
ter systems; (ii) 5-HT exerts an inhibitory inﬂuence on the
nicotine-evoked release of NA, but partial serotonergic lesions
do not inﬂuence the release of ACh at a presynaptic level and
(iii) presynaptic modulatory mechanisms involving auto- and
heteroreceptors may be conserved on ﬁbres spared by the
lesions.
© 2002 Elsevier Science Inc. All rights reserved.
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INTRODUCTION
Alzheimer’s disease (AD) is a neurodegenerative disease that has
become a topic of increasing interest during the last decades. In
order to learn more about both the processes taking place in a
degenerating brain and their relations to behavioural alterations,
attempts have been made to develop animal models simulating
aspects of AD from a neuroanatomical, neurochemical or/and
behavioural point of view (e.g. [35,39]). Many such models were
based on the idea that the cognitive impairments found in AD
(principally recent memory impairments in the early stages of
the disease) are due to the loss of cholinergic fibres in structures
of the basal forebrain innervating the cortex and the hippocam-
pus; this idea led to the so-called “cholinergic hypothesis of
age-related cognitive dysfunctions” [3,4,14,16]. Although alter-
ations of cholinergic systems are recognised to play a prominent
role in dysfunctions related to AD, or even at a less dramatic level
to ageing, it is noteworthy that other neurotransmitter systems,
such as the serotonergic, noradrenergic or GABAergic systems,
are also involved in cognitive functions [12,17].
Using neurotoxins, it is possible to selectively destroy one or
more of these systems in order to study their functional implica-
tions. It is even possible to combine some neurotoxic lesions to
investigate the role of interactions between transmitter systems.
For instance, the cholinergic neurons of the basal forebrain can be
selectively damaged by 192 IgG-saporin [48] and the serotonergic
neurons of the mesencephalic raphé by 5,7-dihydroxytryptamine
(5,7-DHT; [44]). Recently, using an approach relying upon
the combined administration of 192 IgG-saporin and 5,7-DHT,
Lehmann and coworkers [29,30] have confirmed that the coopera-
tion between cholinergic and serotonergic mechanisms took part
in cognitive functions such as spatial working memory (see also
[5,9–11]). One of these studies [29] focused on the hippocampus,
where, as is the case in any transmitter system of the brain or the
periphery, the release of acetylcholine (ACh) and serotonin (5-HT)
is regulated both by extrinsic and intrinsic (local) neuropharma-
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cological mechanisms. The intrinsic mechanisms modulating the
neurotransmitter release involve auto- and heteroreceptors located
on axon terminals [45]. In the hippocampus, the modulation of
this release involves, e.g., M2 autoreceptors and 5-HT1B heterore-
ceptors on cholinergic terminals, 5-HT1B autoreceptors and α2
heteroreceptors on the serotonergic ones, and α2 autoreceptors and
nicotine heteroreceptors (nAChRs) on the noradrenergic ones [45].
Among these few receptors, only the nAChR on the noradrenergic
terminals is excitatory. Knowing whether and how these transmit-
ter systems and their receptors work after lesions or in models of
degenerative disorders may be of importance as they may also be
potential targets for drug therapies aimed at enhancing or blocking
neurotransmission.
In a series of previous studies, we have started to investigate
such modulatory mechanisms in the denervated hippocampus.
To that end, we have used nonselective hippocampal denervation
models (aspirative or electrolytic lesions of the fimbria-fornix
pathways) combined or not with intrahippocampal grafting of fetal
neurons (e.g. [13,26,28,43]). It was found that all auto- and het-
eroreceptors investigated (e.g., M2, 5-HT1B, α2, nAChR) showed
more or less close-to-normal functional characteristics (though
some of them indicated weak up- or downregulations), whether
on the spared terminals in lesion-only rats or on the terminals of
grafted neurons. There is, however, a potential problem with such
unselective lesions, namely that the release and the modulatory
mechanisms investigated on the terminals of a particular neuro-
transmitter system may also be influenced by damage to other
systems, rather than only by changes at the level of presynaptic
receptors.
Therefore, the present study aimed at furthering these investi-
gations using neurotransmitter-specific lesions. Using slices from
the dorsal two thirds of the hippocampus selectively deprived
of cholinergic or/and serotonergic afferents, we characterised
the electrically evoked release of ACh, noradrenaline (NA) and
5-HT, as well as their modulation by auto- and heteroreceptors.
The ACh- and nicotine-evoked release of NA (via nAChRs) was
also investigated. The lesions were produced by injections of 192
IgG-saporin into the septal region and by injections of 5,7-DHT
into the fimbria-fornix/cingular bundle pathways. Biochemical
markers such as the ChAT activity or 5-HT, 5-hydroxyindolacetic
acid (5-HIAA) and NA concentrations were also measured in a
ventral portion of the hippocampus in order to estimate the extent
of the denervations.
MATERIALS AND METHODS
Chemicals and Drugs
Chemicals and drugs were obtained from the following sources:
[1-14C]acetyl coenzyme A (52 mCi/mmol) and [methyl-3H]choline
chloride (82 Ci/mmol) from Amersham-Pharmacia, Freiburg,
Germany; hemicholinium-3 from Chemcon, Freiburg, Germany;
5-[1,2-3H(N)]hydroxytryptamine creatinine sulphate ([3H]5-HT,
21.8 Ci/mmol) and [3H]norepinephrine (55 Ci/mmol) from NEN
Life Sciences, Frankfurt, Germany; 6-nitro-2-(1-piperazinyl)-
quinoline (6-nitroquipazine) from RBI, Biotrend, Köln, Ger-
many; acetylcholine chloride, acetyl coenzyme A, desipramine
hydrochloride, hexamethonium chloride, nicotine hydrogen tar-
trate, oxotremorine sesquifumarate, physostigmine hemisulphate
and tetrodotoxin from Sigma Aldrich Chemie GmbH, Steinheim,
Germany; mecamylamine hydrochloride from Merck, Sharpe and
Dohme; 3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrollo[3,2-b]pyrid-5-one
(CP 93,129) was a gift from Dr. Pagani, Pfizer Inc., Groton, USA,
and 5-bromo-6-(2-imidazolin-2-ylamino)-quinoxaline tartarate
(UK 14,304) a gift from Pfizer, Sandwich, Kent, UK.
Subjects
All procedures involving animals and their care were conducted
in conformity with the international guidelines that are in com-
pliance with national and international laws and policies (Council
directive #87848, October 19, 1987, Ministère de l’Agriculture
et de la Foreˆt, Service Vétérinaire de la Santé et de la Protection
Animales; permission #6212 to J.-C. C. and 6714-bis to H. J.;
O. L. under the responsibility of J.-C. C.) and international (NIH
publication, no. 80-23, revised 1996) laws and policies.
The study used 36 (21 for electrically evoked transmitter release
and 15 for NA release experiments induced by nAChR stimulation,
respectively) male Long–Evans rats aged of 3 months and weighing
about 320 g at the time of surgery. They were housed individually
in transparent Makrolon cages (42 cm × 26 cm × 15 cm) under a
12 h/12 h dark/light cycle (lights on at 0700 h), with ad lib. access to
food and water. The colony and testing rooms were under controlled
temperature (21◦C).
Surgery
All surgical procedures were performed under aseptic conditi-
ons, using sodium pentobarbital anaesthesia (65 mg/kg, i.p.; Sanofi,
France). All rats sustained two surgical operations conducted in
two steps. In the first step, rats were subjected to an injection
into the fimbria-fornix/cingular bundle (FiFx/CB) of either 8µg
of 5,7-DHT (in 0.64µl of saline containing 20 mg/ml ascorbic
acid; Sigma, St. Louis, USA) or its vehicle (0.64µl). Twenty min-
utes before anaesthesia, all rats were injected with desipramine
(25 mg/kg, i.p., in saline) to protect the noradrenergic system from
the 5,7-DHT (e.g. [8]).
In the second step, 1 week later, rats were subjected to an
injection into the medial septum/vertical limb of the diagonal
band of broca of either 0.4µg of 192 IgG-saporin (in 0.4µl of
phosphate-buffered saline (PBS), Chemicon, Temecula, CA, USA)
or its vehicle (0.4µl PBS).
All injections were performed stereotaxically through a
1µl-Hamilton syringe according to coordinates of the Paxinos and
Watson brain atlas [40]. For injection of 5,7-DHT or its vehicle,
coordinates were (in mm from Lambda): AP = +5.7, ML = ±0.9,
DV = −4.0 for the fimbria-fornix (0.2µl/site); AP = +5.7, ML =
±0.4, DV = −2.2 for the cingular bundle (0.12µl/site). The in-
cisor bar was set at 3.0 mm below the interaural line. For injection
of 192 IgG-saporin or its vehicle, coordinates were (in mm from
Bregma): AP = +0.6, ML = ±0.2, DV = −7.2 for the vertical
limb of the diagonal band of broca (vBDB; 0.1µl/site) and DV =
−6.5 for the median septum (MS; 0.1µl/site). The incisor bar was
set at the level of the interaural line. On each site, the needle was left
in situ after each injection for 6 min before being retracted slowly.
In summary, rats received injections of NaCl into the FiFx/CB
followed by 0.4µg of 192 IgG-saporin into the MS/vBDB (saporin
lesion, SAPO, n = 9), injections of 8µg of 5,7-DHT followed by
PBS (5,7-DHT lesion, DHT, n = 9) or both injections of neuro-
toxins (combined lesions, SAPO+DHT, n = 10). Sham-operated
rats received both injections of vehicle (SHAM, n = 8).
Dissection of the Hippocampus and Neurochemical Determinations
Four to ten weeks after lesion surgery (and 13–14 weeks for
the experiments on nAChR-evoked release of NA), the rats were
sacrificed by decapitation, their brains quickly removed, both hip-
pocampi dissected free and the ventral third of each hippocampus
divided in two. One half of the ventral third was homogenised in
1 ml 0.32 M sucrose (in 2.5 mM HEPES, pH 7.4) in a Potter Elve-
hjem glass/teflon homogeniser (8 strokes at 500 rpm). From this
crude homogenate, a 20-µl sample was diluted with 180µl 0.1 N
NaOH and used for measurement of protein according to Lowry
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et al. [32]. A 100-µl sample of the homogenate was stored at−80◦C
until determination of ChAT activity according to Fonnum [19]. A
300-µl aliquot was mixed with 300µl of 0.2 N HClO4 (containing
250 mg Na2SO3 and 200 mg Na2EDTA/l) and stored at −80◦C
until determination of NA, 5-HT and 5-HIAA by HPLC with
electrochemical detection. Following thawing, the latter samples
were centrifuged (10 min at 17,000× g; 4◦C) and the supernatants
filtered using Millex-GV4 (0.22µm; Millipore GmbH, Eschborn,
Germany) filters. Twenty microlitres of the filtrated supernatants
were injected onto a reversed phase HPLC column (Luna 5µm C8;
250 mm×4.6 mm column; Phenomenex, Aschaffenburg, Germany)
and separation was performed at 30◦C at a flow of 1 ml/min (pump
model 480, Gynkotek, München, Germany). The mobile phase
had the following composition (per litre): 3.9 g sodium acetate,
4.0 g citric acid (monohydrate), 114 mg 1-octanesulfonic acid
(sodium salt), 35.7 mg Na2EDTA, 138.1 ml methanol and 7.15 ml
ethanol (pH adjusted to 4.2 with acetic acid). The amounts of
the monoamines and 5-HIAA were determined using the electro-
chemical detector INTRO (Antec, Leyden, The Netherlands) set at
800 mV (at 30◦C) and a standard calibration curve. The detection
limits were 3 pg for NA, 6 pg for 5-HIAA and 7.5 pg for 5-HT.
Accumulation and Electrically Evoked Release of [3H ]Choline,
[3H ]5-HT or [3H ]NA
The two dorsal thirds were cut in 350µm slices using a McIl-
wain tissue chopper. The slices were distributed to three Petri
dishes containing 2 ml Krebs–Henseleit (KH) buffer with either
[3H]choline (0.1µM for ACh release experiments), [3H]5-HT
(0.1µM for 5-HT release experiments) or [3H]NA (0.1µM for
NA release experiments), and incubated for 45 min at 37◦C under
carbogen. The KH solution had the following composition (in
mM): NaCl, 118; KCl, 4.8; CaCl2, 1.3; MgSO4, 1.2; NaHCO3,
25; KH2PO4, 1.2; glucose, 10; ascorbic acid, 0.6; Na2EDTA,
0.03; saturated with carbogen, pH adjusted to 7.4. After incu-
bation, 24 slices were transferred into superfusion chambers (12
chambers per superfusion apparatus, 1 slice per chamber) and
superfused with oxygenated KH buffer (37◦C) at a rate of 0.6 ml/
min. The superfusion medium was supplemented routinely with
hemicholinium-3 (10µM; for ACh release experiments, 9 cham-
bers), 6-nitroquipazine (1µM; for 5-HT release experiments, 9
chambers) or with desipramine (1µM; for NA release, 6 cham-
bers). Fractions (4 min) to be measured were collected from 45 min
of superfusion onwards.
The release of [3H]ACh, [3H]5-HT or [3H]NA, respectively,
was induced by two electrical field stimulations (360 rectangular
pulses at 3 Hz, 2 ms, 4 V/chamber, 26–28 mA) after 53 min (S1),
and after 81 min (S2) of superfusion. Drugs to be tested were added
to the superfusion medium of some chambers from 12 min be-
TABLE 1
ChAT ACTIVITY (nmoles/mg PROTEIN/min) AND CONCENTRATION OF MONOAMINES (ng/mg PROTEIN) IN HOMOGENATES PREPARED FROM THE MOST
VENTRAL PORTION OF THE HIPPOCAMPUS OF SHAM (n = 8), SAPO (n = 9), DHT (n = 9) AND SAPO+ DHT (n = 10) RATS
Groups
Variable SHAM SAPO DHT SAPO + DHT
ChAT activity 0.63 ± 0.04 0.07 ± 0.02 (−89%)* 0.69 ± 0.05 (+10%) 0.04 ± 0.01 (−94%)*
Concentration of 5-HT 4.69 ± 0.44 5.44 ± 0.42 (+16%) 2.08 ± 0.21 (−56%)* 2.68 ± 0.35 (−43%)*
Concentration of 5-HIAA 5.40 ± 0.66 4.81 ± 0.59 (−11%) 2.36 ± 0.33 (−56%)* 3.19 ± 0.26 (−41%)*
Concentration of NA 5.99 ± 0.52 8.69 ± 0.73 (+45%)* 5.73 ± 0.34 (−4%) 7.70 ± 0.83 (+29%)
Values are the mean± SEM. The percent variation compared to controls is indicated in parentheses.
∗ Significantly different from SHAM rats, p < 0.05.
fore the second stimulation onwards. At the end of the experiment
(after 101 min of superfusion) the radioactivity of superfusate sam-
ples and slices (dissolved in 250µl Soluene 350, Packard, Frank-
furt, Germany) was determined by liquid scintillation counting. The
“fractional rate of tritium outflow” (in percent of tissue tritium per
minute) was calculated as: (pmoles tritium outflow per minute) ×
100/4 × (pmoles tritium in the slice at the start of the corresponding
4-min period). The “basal tritium outflow” in the fraction preced-
ing S1 (i.e., from 49 to 53 min of superfusion) is given either in
absolute terms (nCi [3H]outflow/4 min) or in relative terms (“frac-
tional rate of tritium outflow per 4 min”). The “stimulation-evoked
overflow of tritium” was calculated by subtraction of the basal out-
flow and is shown either in absolute terms (“nCi” [3H]overflow) or
in relative terms (in percent of the tritium content of the slice at the
onset of the respective stimulation period). Effects of drugs added
before S2 were determined as the ratio of the overflow evoked by
the corresponding stimulation period (S2/S1) and compared to the
appropriate control ratio (no drug addition before S2).
nAChR Stimulation-Evoked Release of [3H ]NA
Hippocampal slices (eight slices from each rat) preincubated
with [3H]NA as above were superfused at a rate of 0.6 ml/min
in chambers (160µl total volume) with oxygenated KH medium
(37◦C) devoid of any reuptake inhibitor. Fractions (4 min) to be
measured were collected from 45 min of superfusion onwards.
During superfusion these slices were stimulated once (S1) after
61 min of superfusion by addition of either nicotine (100µM), or
ACh (100µM, in the presence of physostigmine (1µM)) for 2 min
to the superfusion medium (rapid changes from the agonist-free
to the agonist-containing and back to the agonist-free KH buffer
was assured by 4-way valves). Determinations of radioactivity and
calculations of the baseline and the nicotine-evoked [3H]overflow
were done as above.
Statistical Analysis
As regards [3H] accumulation in the slices ([3H]choline,
[3H]5-HT or [3H]NA) and the average amount of [3H]overflow
evoked by S1, mean values± SEM were obtained from the pooled
single values of all the rats subjected to the same surgical treatment
(from each rat, up to 53 slices). Concerning the effects of drugs on
electrically evoked [3H]overflow, the corresponding S2/S1 ratios of
slices from rats with the same surgical and experimental treatment
were pooled. All data were analysed by parametric analysis of
variance (ANOVA) or by the Kruskal–Wallis test (nonparametric
ANOVA). Where appropriate, they were followed by 2 × 2 com-
parisons based on the Newmann–Keuls test (parametric) or on the
multiple comparisons test of Dunn (nonparametric). T-tests were
also used where appropriate [49].
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RESULTS
Neurochemical Determinations
In order to quantify the changes in the density of choliner-
gic, serotonergic and noradrenergic innervation caused by selective
cholinergic and serotonergic lesions, several neurochemical mark-
ers were measured in the ventral part of the hippocampus (not used
for slice preparations). These data are shown in Table 1. ANOVA
of the ChAT activity showed a significant Group effect [F (3,32) =
110.58, p < 0.001], which was due to a significant reduction
of activity in SAPO (−89%) and SAPO + DHT (−94%) rats as
compared to their Sham-operated counterpart, but also to DHT
rats (p < 0.001, for all comparisons). ANOVA of the concentra-
tions of 5-HT and 5-HIAA also showed a significant Group effect
[F (3,32) = 19.64 and 8.75, respectively, p < 0.001], which was
due to a significant reduction of the concentration of both markers
in DHT (−56% in each) and SAPO+DHT rats (−43 and −41%)
as compared to the Sham-operated rats (p < 0.01 for all compar-
isons). The 5-HIAA/5-HT ratios did not differ significantly among
groups [F (3,32) = 1.87; not shown]. Finally, ANOVA of the NA
concentration also yielded a significant Group effect, which was
due to a significantly higher concentration of NA in SAPO rats as
compared to SHAM (+45%) or to DHT rats (p < 0.05 in both
cases). In SAPO + DHT rats, the concentration of NA was also
higher than in Sham-operated rats (+29%), but failed to reach sig-
nificance (p = 0.08).
Accumulation of [3H ]Choline, [3H ]5-HT
or [3H ]NA by Hippocampal Slices
Figure 1 shows the accumulation of [3H] in hippocampal slices
preincubated with [3H]choline, [3H]5-HT and [3H]NA. ANOVA
of [3H]choline accumulation values (Fig. 1A) showed a significant
Group effect [F (3,184) = 29.0, p < 0.001], which was due to
an accumulation of [3H]choline that was significantly reduced in
rats from groups SAPO (−25%) and SAPO + DHT (−40%), as
compared to group SHAM or DHT (p < 0.001). Also, in SAPO+
DHT rats, the [3H]choline accumulation was significantly lower
than in SAPO rats (p < 0.01).
ANOVA of the [3H]5-HT accumulation values (Fig. 1B) also
showed a significant Group effect [F (3,182) = 61.28, p < 0.001],
which was due to a significant reduction of the accumulation of
[3H]5-HT in DHT (−56%) and SAPO + DHT rats (−42%), as
compared to SHAM or SAPO rats (p < 0.001 in all cases). Also,
in SAPO+DHT rats, the [3H]5-HT accumulation was significantly
higher than in DHT rats (p < 0.05).
Concerning the accumulation of [3H]NA (Fig. 1C), ANOVA
showed no significant Group effect [F (3,121) = 1.13].
Absolute Basal Outflow of [3H ]
Following preincubation with either [3H]choline, [3H]5-HT or
[3H]NA, hippocampal slices were superfused continuously with
medium containing the choline reuptake inhibitor, hemicholi-
nium-3, the 5-HT reuptake inhibitor, 6-nitroquipazine, or the NA
reuptake inhibitor, desipramine, for ACh release experiments,
5-HT release experiments or NA release experiments, respectively.
During superfusion, release of tritiated transmitters from dorsal
hippocampal tissue was triggered by electrical field stimulation.
In Fig. 2, examples of the fractional rates of basal and evoked
[3H]outflow (relative in percent of tritium accumulation) from hip-
pocampal slices (means±SEM) of the four groups of rats (SHAM,
5,7-DHT, SAPO and SAPO+5,7-DHT) are shown. Although both
basal and evoked outflow of tritium represent a mixture of tritiated
compounds, for convenience, we will use the expression “outflow”
(or “evoked overflow”) of [3H]ACh, [3H]5-HT or [3H]NA, here-
FIG. 1. Accumulation of [3H] in hippocampal slices preincubated with
[3H]choline (A), [3H]5-HT (B) or [3H]NA (C). Data are the mean±SEM
[3H] accumulation expressed in pmoles/slice. Number of rats per group:
five to six; the minimal and maximal numbers of slices per column are
indicated in parentheses. ∗∗∗ Significantly different from SHAM, p < 0.05
(see Section “RESULTS” for other differences).
after, for slices incubated with [3H]choline, [3H]5-HT or [3H]NA,
respectively.
The effects of the lesions on the basal outflow of [3H]choline,
[3H]5-HT or [3H]NA from hippocampal slices were investigated
by comparing the fractional rates of [3H]outflow (expressed either
as percent of tissue [3H] or in nCi) in the fraction immediately
preceding S1 (see Fig. 2). Hereafter, absolute outflow refers to
values in nCi and relative outflow to values in percent of tissue [3H].
Figure 3A shows that the cholinergic lesion had a clear-cut
effect on the absolute basal outflow of [3H]ACh, an observa-
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FIG. 2. Time course of [3H]outflow (±SEM) from slices of the dorsal rat hippocampus preincubated with [3H]choline (A), [3H]5-HT (B) or
[3H]NA (C). The hippocampal slices were prepared from Sham-operated rats (SHAM), rats subjected to 192 IgG-saporin lesions (SAPO),
to 5,7-DHT lesions (DHT) or to a combination of both lesions (SAPO+ DHT). After incubation, the slices were superfused continuously
in the presence of the appropriate reuptake blocker (see Section “MATERIALS AND METHODS”) and, at two occasions (after 53 and
81 min of superfusion) exposed to an electrical field stimulation (S1 and S2; see horizontal bars). The [3H]outflow per minute is expressed
as a percentage of tissue [3H] at the start of the corresponding fraction. The number of slices considered per group of rats is shown in the
upper corner of each figure.
tion confirmed by an ANOVA that revealed a significant Group
effect [F (3,184) = 25.91, p < 0.001]. Two by two compar-
isons showed that this effect was due to a basal outflow that
was significantly lower in SAPO (−31%) and SAPO + DHT
(−44%) rats, as compared to Sham-operated rats, but also to
DHT rats (p < 0.001). Furthermore the outflow was signifi-
cantly lower in the SAPO + DHT as compared to the SAPO rats
(p < 0.05).
Serotonergic lesions reduced the absolute basal outflow of
[3H]5-HT as shown by a significant Group effect [F (3,181) =
59.62, p < 0.001]. This effect was due to significantly lower basal
outflow values in the DHT and SAPO+DHT rats (p < 0.001) as
compared to SHAM and SAPO rats. Moreover, the absolute basal
outflow in DHT rats was significantly lower than in SAPO+DHT
rats (p < 0.05).
There was no significant Group effect on the absolute basal
outflow of [3H]NA [F (3,121) < 1.0; Fig. 3C].
Relative Basal Outflow of [3H ]
As to the relative basal outflow of [3H], ANOVA of the
[3H]choline values (Fig. 3A) showed a significant Group effect
[F (3,184) = 3.32, p < 0.05] due to values that were significantly
lower in DHT as compared to SAPO+ DHT rats.
Also the ANOVA of the relative basal outflow of [3H]5-HT
revealed a significant Group effect [F (3,182) = 7.73, p < 0.001;
Fig. 3B]. It was due to an outflow that was significantly lower in
all three lesion groups (DHT: −7%; SAPO: −13%; SAPO+DHT:
−11%) as compared to group SHAM (p < 0.05, at least).
The absolute basal outflow of [3H]NA (Fig. 3C) was not altered
by the lesions [F (3,121) = 1.25].
Absolute Evoked Overflow of [3H]ACh, [3H]5-HT and [3H]NA
From Fig. 4A, it becomes clear that the cholinergic lesions
had a dramatic effect on the absolute evoked overflow of [3H]
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FIG. 3. Basal outflow of [3H] in hippocampal slices preincubated with
[3H]choline (A), [3H]5-HT (B) or [3H]NA (C). Data are the mean±SEM.
The outflow of [3H] is indicated as an absolute (in nCi; solid bars) or
a relative (in percent of tissue [3H]; hatched bars) accumulation. Data
were from Sham-operated rats (SHAM), rats subjected to 192 IgG-saporin
lesions (SAPO), to 5,7-DHT lesions (DHT) or to a combination of both
lesions (SAPO+DHT). Number of rats per group: five to six; the number
of slices considered per group is indicated above the bars. ∗ Significantly
different from SHAM, p < 0.05, ∗∗∗ p < 0.001 (see Section “RESULTS”
for other differences).
(S1 in nCi). This was confirmed by an ANOVA, which showed a
significant Group effect [F (3,183) = 180.12, p < 0.001] due to
values that were significantly lower in SAPO (−95%) and SAPO+
DHT (−94%) rats, as compared to SHAM, but also to DHT rats
(p < 0.001, in each case).
ANOVA of the absolute evoked overflow of [3H]5-HT (Fig. 4B,
solid bars) also showed a significant Group effect [F (3,182) =
31.55, p < 0.001]. This effect reflected a release that was sig-
nificantly reduced in DHT rats as compared to SHAM (−57%),
FIG. 4. Electrically evoked outflow of [3H] in hippocampal slices prein-
cubated with [3H]choline (A), [3H]5-HT (B) or [3H]NA (C). Data are the
mean ± SEM. The outflow of [3H] is indicated as an absolute (in nCi;
solid bars) or a relative (in percent of tissue [3H]; hatched bars) accu-
mulation. Data were from Sham-operated rats (SHAM), rats subjected to
192 IgG-saporin lesions (SAPO), to 5,7-DHT lesions (DHT) or to a com-
bination of both lesions (SAPO + DHT). Number of rats per group: five
to six; the number of slices considered per group is indicated above the
bars. ∗ Significantly different from SHAM, p < 0.05, ∗∗∗ p < 0.001 (see
Section “RESULTS” for further differences).
SAPO or SAPO+DHT rats, and in SAPO+DHT rats (−40%) as
compared to either of the three other groups (p < 0.001).
Concerning the evoked absolute release of [3H]NA (Fig. 4C),
ANOVA showed no significant Group effect [F (3,121) < 1.0].
Relative Evoked Overflow of [3H ]ACh, [3H ]5-HT and [3H ]NA
It is evident, that the cholinergic lesions also had a dramatic
effect on the relative amount of [3H] released (S1 in percent of
tissue [3H]), as shown in Fig. 4A. This was confirmed statistically,
as the ANOVA showed a significant Group effect [F (3,183) =
307.20, p < 0.001], which was due to a significant reduction of the
relative release of [3H]ACh in SAPO (−93%) and SAPO + DHT
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(−94%) rats, as compared to the SHAM, but also to the DHT rats
(p < 0.001).
ANOVA of the relative amount of [3H]5-HT released (Fig. 4B)
also showed a significant Group effect [F (3,182) = 3.98,
p < 0.001], which was due to the fact that the release in DHT
rats was significantly lower than in SHAM rats (−13%). Also
in SAPO rats was the release significantly lower than in SHAM
(−12%) or SAPO+ DHT rats (p < 0.05). In SAPO+ DHT rats,
the release was significantly higher than in DHT rats (p < 0.05).
Finally, as concerns the relative release of [3H]NA (Fig. 4C),
ANOVA also showed a significant Group effect [F (3,121) = 2.77,
p < 0.05], which was due to a release that was significantly higher
in DHT rats as compared to SAPO rats (p < 0.05).
Effects of Auto- and Heteroreceptor Agonists on Evoked
ACh Release
The data were first expressed as S2/S1 ratios of the values
found after application of a drug and subsequently converted into
a percentage of the appropriate control ratio (S2/S1 without ap-
plication of the drug). Modulation of the evoked [3H]ACh release
via 5-HT1B heteroreceptors and muscarinic autoreceptors was
studied by measuring the effects on the electrically evoked over-
flow of the 5-HT1B agonist CP 93,129 and the muscarinic agonist
oxotremorine (1µM, each).
Addition of CP 93,129 to the superfusion medium before S2
induced an inhibition of the evoked [3H]overflow in groups SHAM
(to 72.8± 2.5% of control) and DHT (to 71.2± 1.3% of control),
an observation supported by a t-test showing a highly significant
difference between CP 93,129 and control values (p < 0.001). In
the two other groups, modulation of the evoked overflow by CP
93,129 could not be measured reliably as there was almost no re-
lease in response to the electrical stimulation (see Fig. 2). Never-
theless, it might be of some interest to indicate that the average
release (in percent of control) amounted 97.9±15.8 in SAPO rats,
and 78.3±13.1 in SAPO+DHT rats. From the few slices (at most
six) that showed a weak release, we found that CP 93,129 reduced
the [3H]overflow by about 50% in SAPO and SAPO+ DHT rats.
Addition of oxotremorine before S2 also induced a clear-cut
inhibition of the evoked overflow of [3H]ACh in SHAM (to 34.1±
2.3% of control) and DHT (to 30.9±1.5% of control) rats. In both
groups, this reduction, as shown by a t-test, was also highly signif-
icant (p < 0.001). Once again, in both other groups, modulation
of the evoked overflow could not be measured reliably, the evoked
overflow being much too weak (see Fig. 2). Just in case, the aver-
age release (in percent of control) amounted 90.4± 18.4 in SAPO
rats, and 51.2 ± 12.3 in SAPO + DHT rats. From the few slices
that showed a weak release, we found that oxotremorine reduced
the [3H]overflow by about 60% in SAPO and SAPO+ DHT rats.
Effects of Auto- and Heteroreceptor Agonists on Evoked 5-HT
Release
Figure 5 shows the effects of the 5-HT1B agonist, CP 93,129,
and the α2 adrenoceptor agonist, UK 14,304 (1µM, each), added
before S2 on the evoked 5-HT release from hippocampal slices
of the four groups of rats. As evident from Fig. 5A, in all four
groups, the 5-HT release was reduced by CP 93,129. This was
confirmed by an ANOVA, which showed a significant Drug effect
[F (1,116) = 1220.0, p < 0.001], but neither a significant overall
Group effect, nor a significant interaction between the two factors
[F (3,116) < 1, in both cases].
UK 14,304 also reduced the evoked overflow of [3H]5-HT in
all four groups (Fig. 5B) and, as demonstrated by an ANOVA,
this reduction was significant: there was a significant Drug effect
[F (1,116) = 1215.3, p < 0.001], but neither an overall Group
effect nor an interaction between these two factors. It should be
FIG. 5. Effect of the autoreceptor agonist CP 93,129 (A) and the α2
receptor agonist UK 14,304 (B) on the electrically evoked overflow of
[3H]5-HT. Each drug was applied to the superfusate 12 min before S2
at a concentration of 1µM. Data are the mean ± SEM evoked overflow
expressed as a ratio (S2/S1) and subsequently normalised by computing
the percent of control values (no drug added to the superfusate). Data
were from Sham-operated rats (SHAM), rats subjected to 192 IgG-saporin
lesions (SAPO), to 5,7-DHT lesions (DHT) or to a combination of
both lesions (SAPO + DHT). Number of rats per group: five to six; the
minimal and maximal numbers of slices per column are indicated in the
parentheses. ∗∗∗ Significantly different (p < 0.001) from the correspond-
ing controls without exogenous agonists (see Section “RESULTS” for
further differences).
noted, however, that two by two comparisons of the effects of UK
13,304 revealed a significant stronger inhibition in the group DHT
as compared to the group SHAM (p < 0.05). A similar comparison
of the groups SAPO+DHT and SHAM did not reach significance
level, although a tendency was also seen (p = 0.08).
Effects on [3H ]NA Release Induced by nAChR Stimulation
In separate experiments on untreated rats, the general prop-
erties of the release of [3H]NA evoked by superfusion for 2 min
with either 100µM nicotine or 100µM ACh (in presence of 1µM
physostigmine) were evaluated. Nicotine-evoked overflow of tri-
tium was reduced to 12.9 ± 1.5% (n = 8; p < 0.001) of control
values in the presence of 0.3µM tetrodotoxin and to 32.7± 3.5%
(n = 8; p < 0.001) of control values in the absence of extracel-
lular calcium; moreover, it was diminished to 3.4 ± 0.8 (n = 4;
p < 0.05) or to 4.5± 1.8% (n = 4; p < 0.05) of control values in
the presence of 100µM hexamethonium or 10µM mecamylamine,
respectively. The overflow of tritium evoked by 100µM ACh
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FIG. 6. ACh- (100µM; solid bars) and nicotine-evoked (100µM; hatched
bars) release of [3H]NA in slices from Sham-operated rats (SHAM), rats
subjected to 192 IgG-saporin lesions (SAPO), to 5,7-DHT lesions (DHT)
or to a combination of both lesions (SAPO + DHT). Number of rats per
group: three to five; the minimal and maximal numbers of slices per column
are indicated in parentheses. Data are the mean ± SEM evoked overflow
expressed as a percent of tissue [3H]. The ACh-evoked overflow was
performed in the presence of 1µM physostigmine. Significant differences
from the corresponding values of SHAM rats: ∗ p < 0.05; ∗∗∗ p < 0.001
(see Section “RESULTS” for further differences).
(in presence of 1µM physostigmine) was reduced to 8.8 ± 1.1%
(n = 4; p < 0.01) of control values in the presence of 0.3µM
tetrodotoxin and to 14.8 ± 2.2% (n = 4; p < 0.01) of control
values in the absence of extracellular calcium; moreover, it was
diminished to 6.5±0.9 (n = 4; p < 0.01) or to 6.6±1.7% (n = 4;
p < 0.001) of control values in the presence of 100µM hexam-
ethonium or 10µM mecamylamine, respectively. These observa-
tions suggest the involvement of nAChRs and of voltage-dependent
sodium channels in this type of evoked overflow, as well as its (at
least partial) dependence from the influx of calcium. Hence, this
type of NA release may be characterised as evoked by stimulation
of neuronal nicotine receptors, action potential-dependent and
exocytotic.
Overall, the accumulation of [3H]NA in the hippocampal slices
of the various rat groups and the corresponding basal outflow of
[3H]NA was comparable to that found in the slices exposed to
electrical field stimulation (see Figs. 1 and 3). Figure 6 shows
the evoked relative overflow of NA in percent of accumulated
[3H] induced by either 100µM ACh (in combination with 1µM
physostigmine; Fig. 6, solid bars), or by 100µM nicotine (Fig. 6,
hatched bars). The Kruskal–Wallis test showed that there was a
significant difference among the four groups (KW = 19.44, p <
0.001) as concerns the release of NA induced by application of
ACh in the presence of physostigmine. Dunn’s test showed that
rats from groups SAPO and SAPO + DHT exhibited a signifi-
cantly higher release than rats from the group SHAM (p < 0.001
in both cases). Similar differences were found on absolute values
(nCi; not illustrated). There was also a significant difference among
the four groups on the relative release of NA induced by nicotine
(KW = 7.68, p = 0.05), and this difference was due to values that
were significantly higher in the group DHT as compared to the
group SHAM (p < 0.05). Although the values in the groups with
cholinergic lesions also exceeded those found in the SHAM rats,
the differences were not significant. Analysis of absolute values
(nCi) yielded similar differences (not shown). In all groups of rats,
the ACh-evoked overflow of NA as well as that evoked by nico-
tine were reduced significantly in the presence of mecamylamine
(10µM; data not illustrated).
DISCUSSION
In the present study, intraseptal injections of 192 IgG-saporin
were combined to lesions of serotonergic hippocampal afferents
by injections of 5,7-DHT. 192 IgG-saporin lesions reduced the
accumulation of [3H]choline (−25%), the release of [3H]ACh
(−93%) and the activity of ChAT (−89%), increased the concen-
tration of NA (+45%) and facilitated the ACh-evoked overflow
of [3H]NA in the hippocampus. 5,7-DHT lesions reduced the
accumulation (−56%) and release (−13%) of [3H]5-HT, the con-
centrations of 5-HT (−56%) and 5-HIAA (−56%), and facilitated
the nicotine-evoked overflow of [3H]NA. The accumulation and
release of [3H]NA were not altered by either lesion. The combi-
nation of both toxins resulted in a combination of their particu-
lar effects. CP 93,129 and oxotremorine reduced the release of
[3H]ACh in control and 5,7-DHT-lesioned rats (by about 30 and
70%, respectively). Because of a too weak release of [3H]ACh, ef-
fects of these drugs could not be measured reliably in rats injected
with saporin. CP 93,129 and UK 14,304 reduced the release of
[3H]5-HT in all groups (by about 65%).
Neurochemical Effects of the Lesions
The concentration of monoamines and the ChAT activity were
measured in the ventral portion of the hippocampus, a portion not
used for the release experiments.
Serotonergic lesions. In 5,7-DHT-lesioned rats, the concentra-
tions of 5-HT and 5-HIAA were reduced by about 56%. These
reductions were slightly smaller than described in previous reports
([1]:−75%; [36]:−70%), but appeared comparable to those found
in a recent experiment [29]. The intraparenchymal injections of
5,7-DHT did not significantly alter the ChAT activity and had no ef-
fect on the concentration of NA, suggesting that the lesions showed
some selectivity.
Cholinergic lesions. Consistent with previous reports, intrasep-
tal injections of 192 IgG-saporin induced a dramatic depletion of
ChAT activity (e.g. [2,37,47]). While these injections had no sig-
nificant effect on the concentration of [5-HT] and [5-HIAA], they
resulted in a 45% increase of the NA concentration. At least part
of this increase probably reflected sprouting of sympathetic fibres,
although one cannot exclude participation of central noradrenergic
fibres, which also have a sprouting potential (e.g. [33]). Sympa-
thetic sprouting is elicited by a cholinergic denervation of the hip-
pocampus and accounts for a protracted increase of noradrenergic
markers [15,27,33]. Harrell et al. [24] recently showed that such
sprouting was also detected in the hippocampus of rats subjected
to 192 IgG-saporin lesions.
Combined lesions. When 192 IgG-saporin and 5,7-DHT were
administered in combination, the particular cholinergic and sero-
tonergic effects were combined. These observations are in line with
experiments in which 5,7-DHT lesions were combined to lesions
damaging cholinergic nuclei without selectivity [36,38,41,42].
They also extend our previous studies in which the toxins were in-
fused in the lateral ventricles [30] or the septal region [29]. Thus,
these data provide further experimental arguments for using com-
binations of selective neurotoxins to study the functional correlates
of interactions between various systems of neurotransmission.
Neuropharmacological Effects of the Lesions
Under the electrical stimulation conditions used herein, the
electrically evoked overflow of tritium by slices preloaded with
[3H]choline, [3H]5-HT or [3H]NA was repeatedly shown to be
Ca2+-dependent and sensitive to tetrodotoxin. Therefore, it can
SELECTIVE LESIONS AND TRANSMITTER RELEASE 379
be considered as representing action potential-induced exocytotic
neurotransmitter release (e.g. [22,23]). Our neuropharmacological
data will be discussed in relation with the release of each of these
transmitters, starting with 5-HT.
Uptake and release of [3H ]5-HT in hippocampal slices. In
line with HPLC data, evidence for 5,7-DHT-induced serotonergic
denervation was also reflected in hippocampal slices, where the
accumulation and both basal and electrically evoked overflow of
[3H]5-HT were decreased. Although the accumulation of [3H]5-HT
certainly resulted from specific uptake (by axon terminals), as well
as from nonspecific binding (e.g., to cell membranes), one may
accept that, in a way or another, part of it was linked to the density
of the serotonergic terminals in the hippocampus, the functional
status of their uptake sites and/or their storage capacity. These re-
marks also apply to the other two transmitters investigated (ACh,
NA). As already obvious from the concentrations of [5-HT] and
[5-HIAA], the lesions were not complete and may thus have been
followed by some sprouting of spared fibres [18,51]. If so, spared
and sprouted fibres may both have contributed to a significant re-
lease of [3H]5-HT in response to electrical field stimulation. This
release was nevertheless weaker than in the Sham-operated rats,
suggesting that the lesion-induced deficit was not compensated for
when the experiment was run. When one compares this reduction
(absolute:−57%; relative:−13%) to that found in previous studies
(absolute:−62%; relative:+32%; [43]) after massive hippocampal
denervation (e.g., by aspiration of the fimbria-fornix pathways),
the effects of selective lesions seemed somewhat different from
those obtained with extensive and unspecific lesion methods.
The release of [3H]5-HT was almost not altered by the nearly
complete damage of the cholinergic fibres innervating the hip-
pocampus. While this observation is in line with the fact that there
is no evidence for a role of nicotinic receptors in the release of
this neurotransmitter (e.g. [45]), it is a bit surprising in the light of
data showing that the release of 5-HT may be under the inhibitory
influence of presynaptic M1 receptors [34]. The latter conclusion
was drawn from results obtained on synaptosomes using K+ stim-
ulations, and thus, under experimental conditions which cannot be
compared to our present ones. Furthermore, as underlined by Vizi
and Kiss [45], the fact that activation of a receptor that is usually
excitatory inhibited the release of 5-HT may seem astonishing. In-
terestingly, in SAPO+DHT rats, the decrease in the accumulation
and the release of [3H]5-HT was not as pronounced as in DHT
rats, and, although weak, this difference was significant for both
variables. As the accumulation and the release of [3H]5-HT were
not facilitated in SAPO rats, the interpretation of this difference
cannot be reduced to a simple effect of the cholinergic denervation
alone. Interactions between cholinergic and serotonergic lesions,
perhaps via functional alterations of terminals belonging to other
transmitter systems, might have taken part in this phenomenon, but
such an issue requires further experimental support.
Uptake of [3H ]choline and release of [3H ]ACh in hippocampal
slices. A cholinergic denervation was also found in the slices from
SAPO and SAPO+DHT rats, where accumulation of [3H]choline
and release of [3H]ACh were reduced by more than 90%. This dra-
matic decrease, which prevented a reliable investigation of presy-
naptic modulatory mechanisms, was very comparable to that found
in a recent experiment investigating the effects of intrahippocam-
pal grafts rich in cholinergic neurons after intraseptal injections of
192 IgG-saporin [6]. Under normal conditions, the modulation of
the release of ACh by cholinergic terminals in the hippocampus
involves, among others, muscarinic, presumably M2 autoreceptors
[50], and 5-HT1B heteroreceptors [45]. Previous experiments had
shown that following lesions to the cholinergic innervation of the
hippocampus, for instance by transsection of the fimbria-fornix, the
amount of M2 immunoreactivity in the hippocampus was reduced
[31], an observation suggesting an alteration of possible substrates
of presynaptic inhibition. It is, however, noteworthy that these find-
ings were not confirmed after 192 IgG-saporin lesions [31]. Already
in our recent experiment [6], the release of [3H]ACh could not be
measured reliably in the presence of oxotremorine or CP 93,129.
However, in the few slices exhibiting some signs of release trig-
gered by an electrical field stimulation, we found that the mus-
carinic and the 5-HT1B receptors responded “normally” to their
respective agonists [6].
Another point deserving discussion concerns the evoked over-
flow of [3H]ACh in rats given 5,7-DHT lesions. As stated above,
5-HT may reduce the release of ACh by activating 5-HT1B het-
eroreceptors located on cholinergic terminals [45]. In the rats
given 5,7-DHT lesions, this reduction should be weaker and one
might therefore expect some facilitation of the electrically evoked
[3H]ACh release. This was found in a recent experiment [7] in
which 5,7-DHT was injected into the lateral ventricles, inducing
an extensive serotonergic denervation of the hippocampus; the
concentrations of 5-HT and 5-HIAA were reduced by more than
90% in the ventral hippocampus. Interestingly, this lesion-induced
facilitation was counterbalanced by intrahippocampal grafts rich
in serotonergic neurons. Why was a similar facilitation of evoked
ACh release not found in the present experiment? We think that the
reason is related to the extent of the serotonergic denervation: while
it was massive in the study by Birthelmer et al. [7], it was only
partial in the present one, thereby enabling the release of enough
5-HT to exert a sufficient activation of the 5-HT1B heterorecep-
tors. This interpretation finds some support in the fact that, using
the same stimulation conditions, the 5,7-DHT lesions reduced the
relative evoked overflow of [3H]5-HT by 13% in the present study
as compared to 47% in the study by Birthelmer et al. [7].
Uptake of [3H ]NA and release of [3H ]NA in hippocampal
slices. The release of [3H]NA was studied in response to electrical
field stimulation or to application of ACh or nicotine acting on
nAChRs. The ACh- or nicotine-evoked overflow was sensitive to
nicotinic antagonists (hexamethonium and mecamylamine) and—
as for electrically evoked overflow of [3H]NA—Ca2+-dependent
and TTX sensitive, indicating that following stimulation of nAChRs
action potentials are induced which lead to exocytotic release of the
neurotransmitter. The nAChRs involved in this effect might belong
mainly to the α3β4 type (see [46]), but possible involvement of
the α7 subtype has also been proposed (see below).
As regards the data from selectively lesioned rats, several issues
require discussion. First, the accumulation, basal and electrically
evoked overflow of [3H]NA were not altered by either lesion.
This accounts for the fact that our cholinergic and serotonergic
lesion methods, whether used separately or in combination, did
not alter the noradrenergic innervation of the hippocampus, or at
least not irreversibly. Second, while the concentration of NA was
increased by the cholinergic lesion, the accumulation of [3H]NA
was not affected. This is not necessarily a contradiction as we have
shown [27] that an increased concentration of NA (as compared
to normal values) due to sympathetic sprouting can be detected
several months before an above normal increase of NA uptake (in
this case by hippocampal synaptosomes) is measured. In addition,
sympathetic sprouting may be more pronounced in the ventral
than in the dorsal hippocampus [27]: while the NA concentration
was measured in a ventral portion of the hippocampus, the accu-
mulation of [3H]NA was determined in slices prepared from the
dorsal two thirds of this structure. A third point concerns the fact
that electrically evoked overflow of [3H]NA was not altered by
the lesions, in contrast to ACh- or nicotine-evoked overflow of
[3H]NA. It is well known that the release of NA can be triggered
by activation of presynaptic nAChRs [45,46]. So far, inhibition
of NA release by activation of presynaptic muscarinic receptors is
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not documented consistently and its modulation by serotonergic
mechanisms requires further studies before clear statements can
be made [45]. However, given the role of presynaptic nAChRs in
NA release, it seemed reasonable to expect that the release of NA
would be deprived of its nicotinic component following the almost
complete cholinergic denervation of the hippocampus. This was
not the case, and an explanation might be that the electrical stim-
ulation conditions were not appropriate to detect lesion-induced
alterations in the nicotinic regulation of NA release.
Fortunately, however, lesion-induced changes in this regulation
could be observed in the experiments using chemical stimulation
of the [3H]NA release (Fig. 6). Here, we found that the cholinergic
lesion facilitated the release of [3H]NA triggered by application
of ACh, and that the serotonergic lesion (not the cholinergic
one) surprisingly facilitated the release triggered by application
of nicotine. While the effects of ACh might be explained by a
lesion-induced upregulation of the nicotinic receptors, it is not
clear why this facilitation did not reach significance in the presence
of nicotine. However, as the release also tended to be increased in
SAPO and SAPO+DHT rats, it seems reasonable to attribute this
failure to too small sample sizes and to replicate this experiment
on a larger number of rats before furthering the discussion on this
point.
Even more enigmatic—at first view—is the significant facili-
tation of [3H]NA release evoked by application of nicotine in the
5,7-DHT-lesioned rats, a result suggesting that some mechanisms
related to this nicotine-evoked overflow of [3H]NA involve a sero-
tonergic inhibitory control. Such an inhibitory mechanism seems,
however, to exist. For instance, Hennings et al. [25] have reported
that monoamine uptake blockers inhibited the nicotine-evoked
overflow of [3H]NA, and that the underlying mechanism did not
involve the neuronal NA transporter. Hennings et al. [25] also re-
ported that fluoxetine, a specific 5-HT reuptake inhibitor, produced
similar effects, but these were attributed to nicotinic antagonist
properties of the drug. Although the question of the subtype of the
nAChR involved in the nicotine-evoked overflow of [3H]NA is still
subject to debate [45,46], it is noteworthy that alpha-bungarotoxin,
an α7-specific nAChR antagonist, attenuates the nicotine-evoked
overflow of [3H]NA in hippocampal slices [20]. Moreover, recent
results obtained with human neuronal α7 nAChRs suggest that
5-HT is able to act on α7 receptors as an antagonist [21]. If a
similar mechanism would work in rats, one might propose that the
facilitated nicotine-evoked overflow of [3H]NA in the rats with
5,7-DHT lesions is due to a reduced inhibitory influence of 5-HT
on nAChRs. If so, the tendencies towards a facilitated release
found in SAPO and that found in DHT rats might involve differ-
ent mechanisms, one being based on a cholinergic lesion-induced
upregulation of nicotinic receptors, the other one being based on
a serotonergic lesion-induced disinhibition of the nAChR. These
speculations invite to further exploration of the issue.
In conclusion, our results confirm that selective neurotoxins
can be combined to enable controlled and selective damage to a
multitude of transmitter systems. Compared with the literature and
previous studies, they also suggest that, under the experimental
conditions used in this study, (i) partial serotonergic lesions do not
influence the release of ACh at the presynaptic level by a reduced
serotonergic activation of the inhibitory 5-HT1B heteroreceptors,
(ii) in the presence of an intact noradrenergic innervation, spared
serotonergic terminals do not upregulate their release capabilities,
probably because this upregulation only appears when the nora-
drenergic fibres are also damaged and do not longer inhibit the
serotonergic terminals and (iii) 5-HT might exert an inhibitory
influence on the nAChR-evoked overflow of NA. Finally, our
results show that presynaptic modulatory mechanisms involving
auto- and heteroreceptors, when measurable (in case of massive
denervation their determination is not longer reliable), may be
conserved on fibres spared by the lesions.
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